{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:14:47Z","timestamp":1793193287465,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.mcna.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T16:56:40Z","timestamp":1637600200000},"page":"43-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The Spectrum of Alcohol Use"],"prefix":"10.1016","volume":"106","author":[{"given":"Shawn M.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2021.08.003_bib1","series-title":"Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH series H-55)","year":"2020"},{"key":"10.1016\/j.mcna.2021.08.003_bib3","series-title":"Alcohol facts and statistics","year":"2020"},{"key":"10.1016\/j.mcna.2021.08.003_bib4","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.003_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"30","key":"10.1016\/j.mcna.2021.08.003_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.15585\/mmwr.mm6930a1","article-title":"Deaths and years of potential life lost from excessive alcohol use - United States, 2011-2015","volume":"69","author":"Esser","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.003_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.293.3.293","article-title":"Correction: actual causes of death in the United States, 2000","volume":"293","author":"Mokdad","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.003_bib8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/acer.13337","article-title":"Heterogeneous costs of alcohol and drug problems across cities and counties in California","volume":"41","author":"Miller","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.003_bib9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/alcalc\/agv127","article-title":"Alcohol use disorders in primary health care: what do we know and where do we go?","volume":"51","author":"Rehm","year":"2016","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.003_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/08897077.2019.1635961","article-title":"The prevalence of unhealthy alcohol and drug use among inpatients in a general hospital","volume":"41","author":"Wakeman","year":"2020","journal-title":"Subst Abus"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.003_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1525-1497.2006.00405.x","article-title":"The severity of unhealthy alcohol use in hospitalized medical patients. The spectrum is narrow","volume":"21","author":"Saitz","year":"2006","journal-title":"J\u00a0Gen Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.003_bib12","first-page":"300","article-title":"Prevalence and variation of clinically recognized inpatient alcohol withdrawal syndrome in the Veterans Health Administration","volume":"14","author":"Steel","year":"2020","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.mcna.2021.08.003_bib13","unstructured":"Liang L, Moore B, Soni A. National inpatient hospital costs: the most expensive conditions by payer, 2017. HCUP Statistical Brief #261. Month 2020. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb261-Most-Expensive-Hospital-Conditions-2017.pdf."},{"issue":"2","key":"10.1016\/j.mcna.2021.08.003_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/002580249003000203","article-title":"The blood alcohol concentration at post-mortem in 175 fatal cases of alcohol intoxication","volume":"30","author":"Heatley","year":"1990","journal-title":"Med Sci Law"},{"key":"10.1016\/j.mcna.2021.08.003_bib15","series-title":"The ASAM principles of addiction medicine","first-page":"107","article-title":"The pharmacology of alcohol","author":"Woodward","year":"2019"},{"issue":"4879","key":"10.1016\/j.mcna.2021.08.003_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.2903550","article-title":"Cellular and molecular mechanisms of drug dependence","volume":"242","author":"Koob","year":"1988","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.003_bib17","first-page":"310","article-title":"How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective","volume":"31","author":"Clapp","year":"2008","journal-title":"Alcohol Res Health"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.003_bib18","first-page":"13","article-title":"Neurochemical mechanisms underlying alcohol withdrawal","volume":"22","author":"Littleton","year":"1998","journal-title":"Alcohol Health Res World"},{"key":"10.1016\/j.mcna.2021.08.003_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-444-62619-6.00006-9","article-title":"Molecular basis of alcoholism","volume":"125","author":"Most","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.mcna.2021.08.003_bib20","series-title":"The ASAM principles of addiction medicine","first-page":"348","article-title":"Laboratory assessment","author":"Merlin","year":"2019"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.003_bib21","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/acer.12442","article-title":"Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease","volume":"38","author":"Stewart","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.mcna.2021.08.003_bib22","series-title":"The ASAM principles of addiction medicine","first-page":"704","article-title":"Management of alcohol intoxication and withdrawal","author":"Wartenberg","year":"2019"},{"issue":"22","key":"10.1016\/j.mcna.2021.08.003_bib23","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMra1407298","article-title":"Recognition and management of withdrawal delirium (delirium tremens)","volume":"371","author":"Schuckit","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2021.08.003_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psychres.2018.02.021","article-title":"Alcohol withdrawal hallucinations in the general population, an epidemiological study","volume":"262","author":"Stephane","year":"2018","journal-title":"Psychiatry Res"},{"issue":"3S","key":"10.1016\/j.mcna.2021.08.003_bib25","first-page":"1","article-title":"The ASAM clinical practice guideline on alcohol withdrawal management","volume":"14","year":"2020","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.mcna.2021.08.003_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-4899-1695-2_12","article-title":"Clinical assessment and pharmacotherapy of the alcohol withdrawal syndrome","volume":"4","author":"Naranjo","year":"1986","journal-title":"Recent Dev Alcohol"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.003_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/BF02600188","article-title":"Risk factors for delirium tremens development","volume":"11","author":"Ferguson","year":"1996","journal-title":"J\u00a0Gen Intern Med"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.003_bib28","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1111\/acer.12529","article-title":"Predictors of severe alcohol withdrawal syndrome: a systematic review and meta-analysis","volume":"38","author":"Goodson","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.003_bib29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/CCM.0000000000002371","article-title":"Occurrence, predictors, and prognosis of alcohol withdrawal syndrome and delirium tremens following traumatic injury","volume":"45","author":"Salottolo","year":"2017","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.003_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2018.10574","article-title":"Will this hospitalized patient develop severe alcohol withdrawal syndrome?: the rational clinical examination systematic review","volume":"320","author":"Wood","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.003_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/alcalc\/agv043","article-title":"Prospective validation study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in medically Ill inpatients: a new scale for the prediction of complicated alcohol withdrawal syndrome","volume":"50","author":"Maldonado","year":"2015","journal-title":"Alcohol Alcohol"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.003_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJM198902093200605","article-title":"Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome","volume":"320","author":"Hayashida","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.003_bib33","article-title":"Benzodiazepines for alcohol withdrawal","author":"Amato","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.003_bib34","first-page":"649","article-title":"Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal","volume":"160","author":"Holbrook","year":"1999","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.003_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jama.1997.03550020076042","article-title":"Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on pharmacological management of alcohol withdrawal","volume":"278","author":"Mayo-Smith","year":"1997","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.003_bib36","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/1060028015585849","article-title":"The role of gabapentin in the management of alcohol withdrawal and dependence","volume":"49","author":"Leung","year":"2015","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.003_bib37","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/TA.0000000000000352","article-title":"Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management","volume":"77","author":"Duby","year":"2014","journal-title":"J\u00a0Trauma Acute Care Surg"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.003_bib38","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/phar.2127","article-title":"Implementation of an ICU-specific alcohol withdrawal syndrome management protocol reduces the need for mechanical ventilation","volume":"38","author":"Heavner","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.003_bib39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.mayocpiqo.2019.06.005","article-title":"Assessment of a hospital-wide CIWA-Ar protocol for management of alcohol withdrawal syndrome","volume":"3","author":"Melkonian","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.003_bib40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jama.1994.03520070039035","article-title":"Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial","volume":"272","author":"Saitz","year":"1994","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.003_bib41","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archinte.162.10.1117","article-title":"Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial","volume":"162","author":"Daeppen","year":"2002","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.003_bib42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.psym.2019.02.002","article-title":"Use of phenobarbital in alcohol withdrawal management - A retrospective comparison study of phenobarbital and benzodiazepines for acute alcohol withdrawal management in general medical patients","volume":"60","author":"Nisavic","year":"2019","journal-title":"Psychosomatics"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.003_bib43","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0196-0644(87)80520-6","article-title":"Intravenous phenobarbital for alcohol withdrawal and convulsions","volume":"16","author":"Young","year":"1987","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.mcna.2021.08.003_bib44","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2016.02.016","article-title":"Phenobarbital compared to benzodiazepines in alcohol withdrawal treatment: a register-based cohort study of subsequent benzodiazepine use, alcohol recidivism and mortality","volume":"161","author":"Askgaard","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"10.1016\/j.mcna.2021.08.003_bib45","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM199903253401203","article-title":"Lorazepam for the prevention of recurrent seizures related to alcohol","volume":"340","author":"D'Onofrio","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.mcna.2021.08.003_bib46","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.003_bib47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-136-3-200202050-00007","article-title":"The effect of controlled drinking in alcoholic cardiomyopathy","volume":"136","author":"Nicolas","year":"2002","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.003_bib48","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.003_bib49","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.003_bib50","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids Reduce risk of death within 28\u00a0days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.003_bib51","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cgh.2017.11.045","article-title":"Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.003_bib52","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/hep.23007","article-title":"Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit","volume":"50","author":"Lucey","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.003_bib53","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1474-4422(07)70104-7","article-title":"Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management","volume":"6","author":"Sechi","year":"2007","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.003_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/jnnp.62.1.51","article-title":"Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy","volume":"62","author":"Caine","year":"1997","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.003_bib55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000499039","article-title":"Thiamine substitution in alcohol use disorder: a narrative review of medical guidelines","volume":"25","author":"Pruckner","year":"2019","journal-title":"Eur Addict Res"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.003_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0735-6757(92)90054-2","article-title":"Is intravenous thiamine safe?","volume":"10","author":"Wrenn","year":"1992","journal-title":"Am J Emerg Med"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.003_bib57","article-title":"Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol","author":"Day","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.003_bib58","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ebiom.2015.08.040","article-title":"Risk of all-cause mortality in alcohol-dependent individuals: a systematic literature review and meta-analysis","volume":"2","author":"Laramee","year":"2015","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.mcna.2021.08.003_bib59","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/acer.13897","article-title":"Drinking risk level reductions associated with improvements in physical health and quality of life among individuals with alcohol use disorder","volume":"42","author":"Witkiewitz","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"issue":"12","key":"10.1016\/j.mcna.2021.08.003_bib60","doi-asserted-by":"crossref","first-page":"e1181","DOI":"10.4088\/JCP.13r08379","article-title":"Reduction of alcohol consumption and subsequent mortality in alcohol use disorders: systematic review and meta-analyses","volume":"74","author":"Roerecke","year":"2013","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.003_bib61","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1176\/appi.ps.201000553","article-title":"Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence","volume":"63","author":"Harris","year":"2012","journal-title":"Psychiatr Serv"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.003_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13722-019-0147-3","article-title":"Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD)","volume":"14","author":"Joudrey","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.003_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0376-8716(03)00134-0","article-title":"Understanding US addiction physicians' low rate of naltrexone prescription","volume":"71","author":"Mark","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.003_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/ajp.150.1.28","article-title":"Network therapy for addiction: a model for office practice","volume":"150","author":"Galanter","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.003_bib65","doi-asserted-by":"crossref","first-page":"e87366","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis","volume":"9","author":"Skinner","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.003_bib66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/ajp.153.2.281","article-title":"Experience of a \"slip\" among alcoholics treated with naltrexone or placebo","volume":"153","author":"O'Malley","year":"1996","journal-title":"Am J Psychiatry"},{"issue":"13","key":"10.1016\/j.mcna.2021.08.003_bib67","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.003_bib68","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1360-0443.2004.00763.x","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review","volume":"99","author":"Bouza","year":"2004","journal-title":"Addiction"},{"issue":"18","key":"10.1016\/j.mcna.2021.08.003_bib69","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.003_bib70","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/JCP.0b013e3181ac5213","article-title":"Targeted naltrexone for problem drinkers","volume":"29","author":"Kranzler","year":"2009","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.mcna.2021.08.003_bib71","series-title":"PCSS providers' clinical support system: MAT training","article-title":"Monitoring of liver function tests in patients receiving naltrexone or extended-release naltrexone","author":"Springer","year":"2014"},{"key":"10.1016\/j.mcna.2021.08.003_bib72","series-title":"Clinical advances in non-agonist therapies","year":"2016"},{"issue":"9","key":"10.1016\/j.mcna.2021.08.003_bib73","article-title":"Acamprosate for alcohol dependence","author":"Rosner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.003_bib74","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder","volume":"175","author":"Reus","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.003_bib75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0005-7916(82)90050-7","article-title":"Alcoholism treatment by disulfiram and community reinforcement therapy","volume":"13","author":"Azrin","year":"1982","journal-title":"J\u00a0Behav Ther Exp Psychiatry"},{"issue":"11","key":"10.1016\/j.mcna.2021.08.003_bib76","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1360-0443.2006.01576.x","article-title":"Topiramate reduces the harm of excessive drinking: implications for public health and primary care","volume":"101","author":"Ma","year":"2006","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.003_bib77","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/acer.12411","article-title":"A\u00a0meta-analysis of topiramate's effects for individuals with alcohol use disorders","volume":"38","author":"Blodgett","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.003_bib78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","author":"Mason","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.003_bib79","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamainternmed.2020.0249","article-title":"Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial","volume":"180","author":"Anton","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.003_bib80","first-page":"181","article-title":"Behavioral treatments for alcohol use disorder and post-traumatic stress disorder","volume":"39","author":"Flanagan","year":"2018","journal-title":"Alcohol Res"},{"key":"10.1016\/j.mcna.2021.08.003_bib81","article-title":"Effectiveness of brief alcohol interventions in primary care populations","volume":"2","author":"Kaner","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2021.08.003_bib82","series-title":"Screening and behavioral Counseling interventions to reduce unhealthy alcohol use in adolescents and adults: an updated systematic review for the U.S. Preventive Services Task Force","author":"O\u2019Connor","year":"2018"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.003_bib83","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/16066350902770458","article-title":"How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous","volume":"17","author":"Kelly","year":"2009","journal-title":"Addict Res Theor"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.003_bib84","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1037\/0022-006X.71.2.302","article-title":"Alcoholics anonymous involvement and positive alcohol-related outcomes: cause, consequence, or just a correlate? A prospective 2-year study of 2,319 alcohol-dependent men","volume":"71","author":"McKellar","year":"2003","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"12","key":"10.1016\/j.mcna.2021.08.003_bib85","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1037\/ccp0000447","article-title":"A\u00a0meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: treatment efficacy by contrast condition","volume":"87","author":"Magill","year":"2019","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"9","key":"10.1016\/j.mcna.2021.08.003_bib86","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/acer.13162","article-title":"Randomized trial of computerized cognitive behavioral therapy for alcohol use disorders: efficacy as a virtual stand-alone and treatment add-on compared with standard outpatient treatment","volume":"40","author":"Kiluk","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"10.1016\/j.mcna.2021.08.003_bib87","doi-asserted-by":"crossref","first-page":"eaax4043","DOI":"10.1126\/sciadv.aax4043","article-title":"Advances in the science and treatment of alcohol use disorder","volume":"5","author":"Witkiewitz","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.mcna.2021.08.003_bib88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addbeh.2016.06.008","article-title":"Mobile technology-based interventions for adult users of alcohol: a systematic review of the literature","volume":"62","author":"Fowler","year":"2016","journal-title":"Addict Behav"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:47:45Z","timestamp":1758419265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712521001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0025712521001115"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.08.003","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Spectrum of Alcohol Use","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}